ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Contructive Bio, a genome engineering start-up founded by University of Cambridge molecular biologist Jason Chin, has secured $58 million in series A financing, bringing its total raised capital to $75 million. Nobel laureate Gregory Winter is joining the company as a board member. Constructive Bio aims to deliver biomanufacturing at industrial scale by synthesizing the genomes of bacteria to produce novel proteins and biopolymers that incorporate noncanonical amino acids. Chin says in a press release that the funding will help the firm achieve its goal of “accelerating genome synthesis and design from years to days.”
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter